Skip to content
ASI Research Lab

The Three Research Monoliths

Medicine. Agriculture. General AI.

Three laboratories, each with a defined mandate, concrete focus areas, and a dated first output. Not categories — specific research, on a timeline.

Monolith 01 — General AI Phase 01 · active

Autonomous multi-agent systems and post-quantum cryptographic infrastructure for the next internet.

  • ASI Master Brain — multi-LLM orchestration
  • PHANTOM Protocol — Kyber-1024 + X25519
  • Autonomous agent task routing & consensus
Monolith 02 — Medicine Dec 2026 [TARGET]

AI diagnostic tools for diseases endemic to South Asia — the diseases Western AI labs do not build for.

  • Dengue severity prediction from clinical data
  • Thalassemia genetic-marker identification
  • Malaria rapid diagnostic support
Monolith 03 — Agriculture ≤ 6 months [TARGET]

Precision farming intelligence and climate modeling for the systems that feed two billion people.

  • Crop-yield models for rice, tea, coconut
  • Sentinel-2 satellite crop-stress detection
  • Monsoon-adaptive irrigation scheduling

Our strength

Built to lead at the frontier.

Deep, specific capability across general AI, cryptography, and applied science — research on a ten-year horizon, not a quarterly one.

01

The ASI Master Brain

A multi-LLM orchestration architecture routing cognitive tasks across Claude, DeepSeek R1, Grok 3, GPT-4o, Gemini, Mistral, and offline local models — one command interface, zero context-switching.

02

PHANTOM Protocol

Post-quantum secure messaging using a hybrid Kyber-1024 + X25519 key encapsulation (NIST ML-KEM), with an on-chain token economy on Base L2.

03

AI-assisted drug discovery

AlphaFold structural predictions applied to dengue NS5 polymerase, malaria PfCRT, and thalassemia beta-globin variants — screening approved compounds for repurposing.

04

Autonomous multi-agent systems

Multi-model consensus mechanisms and cryptographically-verified communication between agents making high-stakes, real-world decisions.

Researchers, partners, and investors who think in decades — work with us →